Discusses Strategic Scenarios and Value Creation Opportunities Regarding Commerzbank April 20, 2026 3:00 AM EDT Antonio Reale - BofA Securities, Research Division Sofie Caroline Peterzens - Goldman ...

The next evolution of the finance function isn’t about controlling cybersecurity spend; it’s about controlling cyber exposure ...

Munich, Germany, April 23, 2026 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (Vivoryon), a clinical stage company developing small molecule medicines for inflammatory and ...

Good morning, and thank you for joining us today for The Hartford's First Quarter 2026 Earnings Call and Webcast. Yesterda ...

Consolidated Revenue -- $136.8 million, up 14.3% driven by growth in Genie Retail Energy (GRE). GRE Revenue -- $132.5 million ...

There’s a general consensus that too much screen time is bad for kids. But what happens when everything in modern society is ...

The new GLB is a significant step forward over its EQB predecessor, offering seven-seat practicality, cutting-edge technology ...

Ian Cleminson reported, As we move into 2025, the one thing that is going to be slightly different for us is that in 2024, we ...

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

Single-dose of miv-cel achieved robust and durable improvements in mobility, reversed disability scores, and eliminated the need for chronic immunotherapies -- outcomes not previously observed in SPS ...

Late-breaking Phase III FENhance 1 and 2 study results showed superiority of investigational fenebrutinib compared to teriflunomide in reducing relapses and brain lesions in relapsing multiple ...